Health Care | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology
NASDAQ | Common Stock
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery.
The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools.
It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies.
The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific.
It sells its products online.
The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
As of December 6, 2023, Abcam plc operates as a subsidiary of Danaher Corporation.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 11, 23 | 0.00 Decreased by -100.00% | 0.19 Decreased by -100.00% |
| Nov 30, 22 | 0.00 Decreased by -100.00% | - |
| Sep 12, 22 | 0.16 Increased by +379.24% | 0.17 Decreased by -2.03% |
| Jun 30, 21 | 0.01 Increased by +133.67% | - |
| Mar 31, 21 | 0.01 Increased by +133.50% | - |
| Dec 31, 20 | 0.04 Decreased by -56.65% | - |
| Sep 30, 20 | 0.03 Decreased by -55.87% | - |
| Jun 30, 20 | -0.04 Decreased by -175.09% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 23 | 101.60 M Increased by +9.72% | 8.40 M Increased by +189.66% | Increased by +8.27% Increased by +164.00% |
| Mar 31, 23 | N/A Decreased by N/A% | N/A Decreased by N/A% | - - |
| Dec 31, 22 | 166.70 M Increased by +38.46% | -9.38 M Increased by 0.00% | Decreased by -5.62% Increased by +27.77% |
| Sep 30, 22 | N/A Decreased by -100.00% | N/A Decreased by -100.00% | - - |
| Jun 30, 22 | 92.60 M Increased by +N/A% | 2.90 M Increased by +N/A% | Increased by +3.13% - |
| Mar 31, 22 | N/A Decreased by N/A% | N/A Decreased by N/A% | - - |
| Dec 31, 21 | 120.40 M Increased by +85.23% | -9.38 M Decreased by -400.00% | Decreased by -7.79% Decreased by -261.96% |
| Jun 30, 21 | 73.75 M Increased by +13.46% | 5.85 M Increased by +87.20% | Increased by +7.93% Increased by +64.99% |